The device, a wrist-worn sensor that uses infrared light to detect the presence and concentration of cardiac troponin-I in the blood through the skin, predicted levels with 90% accuracy within 5 minutes.
Modern surgical strategies and mechanical circulatory support yield excellent survival even among the sickest patients with acute pulmonary embolism, the AHA notes in a new scientific statement.
As compared with low-molecular-weight heparin, direct oral anticoagulants (DOACs) were more clinically effective and more cost-effective for treating cancer-associated thrombosis.